G. Rodgers

G. Rodgers, J. Fisher, W. George, 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Home prothrombin time monitoring: A literature analysis

G. Rodgers, R. Robetorye, David T. Yang, 2004, American journal of hematology.

Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical Perspective

M. Aapro, P. Gascón, G. Rodgers, 2019, Front. Pharmacol..

MANAGING PATIENTS WITH CHEMOTHERAPY-INDUCED ANEMIA

G. Rodgers, 2008 .

That Were Tunel-positive (pe-positive/fitc-positive) Microchips: an All-language Literature Survey Includ- Ing Books and Patents

G. Rodgers, M. M. Flanders, R. Crist, 2022 .

Acquired abnormalities of platelet function [2]

J. George, S. Cramer, S. Buys, 1991 .

Establishing an anemia clinic for optimal erythropoietic-stimulating agent use in hematology-oncology patients.

G. Rodgers, J. Gilreath, D. Sageser, 2008, Journal of the National Comprehensive Cancer Network : JNCCN.

ADAMTS13 promotes angiogenesis and modulates VEGF-induced angiogenesis.

Manfai Lee, G. Rodgers, E. Rodansky, 2012, Microvascular research.

Analytic validation and clinical evaluation of the STA LIATEST immunoturbidimetric D-dimer assay for the diagnosis of disseminated intravascular coagulation.

G. Rodgers, C. M. Lehman, Lori W. Wilson, 2004, American journal of clinical pathology.

Intravenous Iron Therapy: A Summary of Treatment Options and Review of Guidelines

G. Rodgers, J. Gilreath, S. B. Silverstein, 2008 .

Laboratory monitoring of warfarin therapy in Utah

G. Rodgers, S. Garr, 1994, American journal of hematology.

Prothrombin time, activated partial thromboplastin time and dilute Russell's Viper Venom times are not shorter in patients with the prothrombin G20210A mutation, and dilute Russell's Viper Venom time may be longer.

B. Shirts, G. Rodgers, K. Smock, 2012, Thrombosis research.

The Effects of a Multifaceted Intervention to Improve Venous Thromboembolism Prophylaxis are Sustained Over Time

R. Pendleton, G. Rodgers, M. Rondina, 2009 .

Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis.

M. M. Rees, G. Rodgers, Matthew M. Rees, 1993, Thrombosis research.

The treatment of venous thromboembolism in special populations.

R. Pendleton, G. Rodgers, M. Rondina, 2007, Thrombosis research.

Prothrombin complex concentrates in emergency bleeding disorders

G. Rodgers, 2012, American journal of hematology.

Polymorphisms in the 5′‐UTR of the tissue factor gene are associated with altered expression in human endothelial cells

G. Rodgers, J. Hoidal, C. Terry, 2004, Journal of thrombosis and haemostasis : JTH.

Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients.

R. Pendleton, G. Rodgers, M. Rondina, 2010, Thrombosis research.

Role of Platelet Adhesion and Aggregation in Antithrombotic Therapy

G. Rodgers, 2022 .

DIAGNOSTIC DILEMMA: PULMONOLOGY

C. Wiener, R. Pendleton, G. Rodgers, 2006 .

Heparin-induced thrombocytopenia is rare in pregnancy.

R. Silver, G. Rodgers, D. Branch, 2001, American journal of obstetrics and gynecology.

Argatroban Dosing of Patients with Heparin-Induced Thrombocytopenia and an Elevated aPTT Due to Antiphospholipid Antibody Syndrome

George M Rodgers, R. Pendleton, G. Rodgers, 2006, The Annals of pharmacotherapy.

Laboratory evaluation of clopidogrel responsiveness by platelet function and genetic methods

G. Rodgers, K. Smock, P. J. Saunders, 2011, American journal of hematology.

Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells.

G. Rodgers, M. Conn, Marion T. Conn, 1990, Blood.

Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.

G. Rodgers, W. Kane, W. H. Kane, 1986, The Journal of clinical investigation.

Parenteral iron therapy options

G. Rodgers, S. B. Silverstein, 2004, American journal of hematology.

Evaluation of a new commercial method for von Willebrand factor multimeric analysis

G. Rodgers, D. Grenache, K. Smock, 2018, International journal of laboratory hematology.

Elderly female with a personal and family history of a bleeding disorder.

E. Lyon, G. Rodgers, K. Smock, 2015, Clinical chemistry.

Pyrrolidine dithiocarbamate abrogates tissue factor (TF) expression by endothelial cells: evidence implicating nuclear factor-kappa B in TF induction by diverse agonists.

G. Rodgers, L. Fitzgerald, C. Orthner, 1995, Blood.

Congenital thrombotic disorders

M. Shuman, G. Rodgers, 1986, American journal of hematology.

Oxidized low‐density lipoprotein increases cultured human endothelial cell tissue factor activity and reduces protein C activation 1

R. E. Pitas, G. Rodgers, J. Weis, 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Elevated hemostatic factor levels as potential risk factors for thrombosis.

J. Sprouse, G. Rodgers, A. Thompson, 2002, Archives of pathology & laboratory medicine.

Hyperparathyroidism associated with polycythemia.

G. Rodgers, 1982, Archives of internal medicine.

Characterization of an inducible endothelial cell prothrombin activator.

G. Rodgers, L. Liu, Li-hua Liu, 1996, Blood.

Enhancement of prothrombin activation on platelets by endothelial cells and mechanism of activation of factor V.

M. Shuman, G. Rodgers, 1987, Thrombosis research.

Implementation of a recombinant factor IX Fc fusion protein extended‐infusion desensitization protocol

G. Rodgers, J. Gilreath, J. McPherson, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

The iron revolution: Keeping abreast of the developments in iron therapy

T. Richards, I. Macdougall, G. Rodgers, 2021, American journal of hematology.

Recombinant activated factor VII: a new weapon in the fight against hemorrhage.

G. Rodgers, D. Branch, 2003, Obstetrics and gynecology.

Excessive anticoagulation in patients with mild renal insufficiency receiving long‐term therapeutic enoxaparin

G. Rodgers, A. Weyman, L. Busby, 2001, American journal of hematology.

New oral anticoagulants may not be effective to prevent venous thromboembolism in patients with antiphospholipid syndrome

G. Rodgers, K. Win, 2014, American journal of hematology.

Cancer- and treatment-related anemia: Clinical Practice Guidelines in Oncology

M. Millenson, G. Demetri, C. Cleeland, 2005 .

Cancer- and treatment-related anemia.

M. Millenson, G. Demetri, C. Cleeland, 2005, Journal of the National Comprehensive Cancer Network : JNCCN.

Development of antithrombin antibodies following surgery in patients with prosthetic cardiac valves.

M. Shuman, G. Rodgers, L. Corash, 1988, Blood.

Laboratory identification of lupus anticoagulants

G. Rodgers, K. Smock, 2009, American journal of hematology.

The inherited thrombophilias: genetics, epidemiology, and laboratory evaluation.

G. Rodgers, D. Ware Branch, G. Buchanan, 2003, Best practice & research. Clinical obstetrics & gynaecology.

A Phase II, double‐blind, randomized, parallel group, dose‐finding study of the safety and tolerability of darexaban compared with warfarin in patients with non‐valvular atrial fibrillation: the oral factor Xa inhibitor for prophylaxis of stroke in atrial fibrillation study 2 (OPAL‐2)

G. Lip, J. Halperin, G. Rodgers, 2015, Journal of thrombosis and haemostasis : JTH.

A high‐performance liquid chromatography method for the serotonin release assay is equivalent to the radioactive method

G. Rodgers, E. L. Frank, K. Smock, 2016, International journal of laboratory hematology.

The D‐dimer assay

G. Rodgers, John C. Schell, Eric D. Johnson, 2019, American journal of hematology.

Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates

R. Pendleton, G. Rodgers, Michelle Wheeler, 2005, American journal of hematology.

Diagnosis and treatment of cancer‐related anemia

G. Rodgers, D. Stenehjem, J. Gilreath, 2014, American journal of hematology.

The Role of Intravenous Iron in the Treatment of Anemia Associated with Cancer and Chemotherapy

G. Rodgers, J. Gilreath, 2019, Acta Haematologica.

Intravenous iron [25]

G. Rodgers, M. Auerbach, 2007 .

High-molecular weight iron dextran: a wolf in sheep's clothing?

D. Cella, G. Chertow, G. Rodgers, 2008, Journal of the American Society of Nephrology : JASN.

Chlamydia species infect human vascular endothelial cells and induce procoagulant activity.

G. Rodgers, M. Woods, R. Fryer, 1997, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

Preeclamptic Sera Stimulate Increased Platelet‐Derived Growth Factor mRNA and Protein Expression by Cultured Human Endothelial Cells

T. Musci, J. Roberts, G. Rodgers, 1991, American journal of reproductive immunology.

Mitogenic activity is increased in the sera of preeclamptic women before delivery.

T. Musci, J. Roberts, G. Rodgers, 1988, American journal of obstetrics and gynecology.

Elevated factor IX activity is associated with an increased odds ratio for both arterial and venous thrombotic events.

G. Rodgers, K. Smock, Andrew R. Wilson, 2013, American journal of clinical pathology.

Treatment of immune‐mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: A retrospective review of 40 patients

G. Rodgers, Joseph E. Spahr, 2008, American journal of hematology.

Discard tubes are not necessary when drawing samples for specialized coagulation testing

Sarah J. Z. Hansen, G. Rodgers, C. M. Lehman, 2010, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events.

G. Rodgers, Hyunhee Kim, David T. Yang, 2006, American journal of clinical pathology.

Portal vein thrombosis after laparoscopic sleeve gastrectomy: presentation and management.

G. Rodgers, D. Cottam, Amit Surve, 2016, Surgery for Obesity and Related Diseases.

Utilization of testing for activated protein C resistance in a reference laboratory.

S. Florell, G. Rodgers, 1996, American journal of clinical pathology.

Inherited thrombotic disorders: An update

S. Florell, G. Rodgers, 1997, American journal of hematology.

Hospital-Based Clinical Implications of the Novel Oral Anticoagulant, Dabigatran Etexilate, in Daily Practice

R. Pendleton, R. Wilcox, G. Rodgers, 2011, Hospital practice.

Acquired cyclic neutropenia: Successful treatment with prednisone

M. Shuman, G. Rodgers, 1982, American journal of hematology.

Avoiding errors in the laboratory evaluation of potent lupus anticoagulants

G. Rodgers, Gopi Penmetsa, K. Smock, 2010, American journal of hematology.

Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency

G. Rodgers, 2009, Thrombosis and Haemostasis.

Laboratory and clinical aspects of inherited thrombotic disorders

G. Rodgers, W. Chandler, 1992, American journal of hematology.

How I manage patients with acquired haemophilia A

G. Rodgers, D. Sborov, 2013, British journal of haematology.

ADAMTS13 and its variants promote angiogenesis via upregulation of VEGF and VEGFR2

Manfai Lee, G. Rodgers, Juan Xiao, 2014, Cellular and Molecular Life Sciences.

Factor V Leiden: death and DNA.

S. Florell, G. Rodgers, 1999, American journal of clinical pathology.

Successful management of intra-abdominal hemorrhage in the presence of severe alcoholic liver disease with activated recombinant factor VII (rFVIIa; NovoSeven): a case report and review of the literature on approved and off-label use of rFVIIa.

G. Rodgers, N. Agarwal, Joseph E. Spahr, 2007, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Enoxaparin once daily vs. twice daily dosing for the treatment of venous thromboembolism in cancer patients: A literature summary

G. Rodgers, Amber H Diaz, J. Gilreath, 2012, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Factor V deficiency caused by a novel missense mutation, Ile417Thr, in the A2 domain

G. Rodgers, M. M. Flanders, S. Kling, 2006, Journal of thrombosis and haemostasis : JTH.

SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functions

S. Tripp, L. Ramdas, R. Benjamin, 2017, PloS one.

Management of thrombosis in women with antiphospholipid syndrome.

G. Rodgers, N. Chandramouli, 2001, Clinical obstetrics and gynecology.

What is the optimal treatment of superior mesenteric vein/portal vein thrombosis after bariatric surgery? Is SMA-directed t-PA the answer?

G. Rodgers, D. Cottam, Amit Surve, 2017, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

Hematologic aspects of human immunodeficiency virus infection: Laboratory and clinical considerations

G. Rodgers, L. Perkocha, 1988, American journal of hematology.

Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells.

J. Roberts, G. Rodgers, R. Taylor, 1988, American journal of obstetrics and gynecology.

Hemostasis Screening Assays

G. Rodgers, C. M. Lehman, 2015 .

Activation of coagulation during routine diagnostic coronary angiography.

J. Muhlestein, G. Rodgers, W. Barry, 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis.

G. Rodgers, D. Branch, D. Branch, 1993, American journal of obstetrics and gynecology.

Improved method of human umbilical arterial endothelial cell culture.

G. Rodgers, J. R. Weis, B. Sun, 1991, Thrombosis research.

Hemostatic properties of normal and perturbed vascular cells

G. Rodgers, 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Induction of tissue factor activity in endothelial cells and monocytes by a modified form of albumin present in normal human plasma.

G. Rodgers, C. Parker, N. Bernshaw, 1992, Blood.

Tissue factor is a major stimulus for vegetation formation in enterococcal endocarditis in rabbits.

T. Drake, G. Rodgers, M. Sande, 1984, The Journal of clinical investigation.

Characterization of the effects of cultured vascular cells on the activation of blood coagulation.

M. Shuman, G. Rodgers, C. Greenberg, 1983, Blood.

The number of receptors for factor VII correlates with the ability of cultured cells to initiate coagulation.

M. Shuman, G. Rodgers, G. Broze, 1984, Blood.

Update on thrombotic thrombocytopenic purpura.

G. Rodgers, J. D. Osborn, 2011, Clinical advances in hematology & oncology : H&O.

A Comparison of Blood Collection in Glass Versus Plastic Vacutainers on Results of Esoteric Coagulation Assays

G. Rodgers, M. M. Flanders, R. Crist, 2003 .

science [coagulation | phlebotomy | management]: A Comparison of Blood Collection in Glass Versus Plastic Vacutainers on Results of Esoteric Coagulation Assays

G. Rodgers, B. Flanders, Bs Mt Ronda Crist, 2003 .

Radioisotopic measurement of plasma kallikrein.

M. Shuman, G. Rodgers, V. Donaldson, 1982, Thrombosis research.

Management of cancer‐associated thrombotic microangiopathy: What is the right approach?

G. Rodgers, T. Werner, N. Agarwal, 2007, American journal of hematology.

Acquired hemophilia a: a current review of autoantibody disease.

G. Rodgers, D. Sborov, 2012, Clinical advances in hematology & oncology : H&O.

leukemia Evidence of increased angiogenesis in patients with acute myeloid

G. Rodgers, P. Shami, J. Hussong, 2013 .

Five Challenging Cases of Hereditary Antithrombin Deficiency Characterized by Thrombosis or Complicated Pregnancy

G. Rodgers, M. Tarantino, A. von Drygalski, 2022, Journal of blood medicine.

Increase in Hematocrit, Hemoglobin and Red Cell Mass in Normal Mice after Treatment with Cyclic AMP 1

G. Rodgers, J. Fisher, W. George, 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Acquired Coagulation Disorders and TTP

G. Rodgers, 2015 .

Enoxaparin, a low-molecular-weight heparin suppresses prothrombin activation more effectively than unfractionated heparin in patients treated for venous thromboembolism.

G. Rodgers, T. Spiro, A. Grosset, 1997, Thrombosis research.

Inappropriate use of enoxaparin in the treatment of deep-vein thrombosis.

G. Rodgers, 1999, The New England journal of medicine.

Formation of factor Va by atherosclerotic rabbit aorta mediates factor Xa-catalyzed prothrombin activation.

R. E. Pitas, G. Rodgers, W. Kane, 1988, The Journal of clinical investigation.

The skin bleeding time test as a predictor of brain bleeding time in a rat model.

J. Macdonald, G. Rodgers, B. Remington, 1994, Thrombosis research.

Comparison of five thrombin time reagents.

G. Rodgers, M. M. Flanders, R. Crist, 2003, Clinical chemistry.

Comparison of functional and antigenic fibrinogen values from a normal population.

G. Rodgers, S. Garr, 1992, Thrombosis research.

Preeclampsia: An endothelial cell disorder

Robert N. Taylor, T. Musci, G. Rodgers, 1990 .

Pediatric reference intervals for uncommon bleeding and thrombotic disorders.

A. Phansalkar, G. Rodgers, W. Roberts, 2006, The Journal of pediatrics.

Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety

G. Rodgers, Stacy A. Voils, M. Creer, 2009, Patient safety in surgery.

Novel antithrombotic therapy.

G. Rodgers, 1993, The Western journal of medicine.

Activated protein C resistance and inherited thrombosis.

G. Rodgers, 1995, American journal of clinical pathology.

A Comparison of Two Commercial ADAMTS13 Activity Assays With a Reference Laboratory Method

G. Rodgers, R. Crist, 2009 .

Regulation of ADAMTS13 Expression in Proliferating Human Umbilical Vein Endothelial Cells

G. Rodgers, S. Kling, Cambria A. Judd, 2007, Pathophysiology of Haemostasis and Thrombosis.

Diagnostic approach to the bleeding disorders

G. Rodgers, C. M. Lehman, 2013 .

Eltrombopag as initial monotherapy for severe aplastic anemia—a case report

G. Rodgers, J. Gilreath, 2018, Annals of Hematology.

On the safety of intravenous iron, evidence trumps conjecture

J. Adamson, I. Macdougall, F. Locatelli, 2015, Haematologica.

Activation of the Renal Erythropoietic Factor by a Cyclic AMP-Dependent Protein Kinase 1

G. Rodgers, J. Fisher, W. George, 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

A haemophilia B patient with severe burn injury: increased requirement for factor IX replacement therapy associated with venous thromboembolism

G. Rodgers, H. Yaish, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Preeclampsia: an endothelial cell disorder.

T. Musci, J. Roberts, G. Rodgers, 1989, American journal of obstetrics and gynecology.

Characterization of the interaction between factor Xa and bovine aortic endothelial cells.

M. Shuman, G. Rodgers, 1985, Biochimica et biophysica acta.

Pediatric reference intervals for seven common coagulation assays.

G. Rodgers, W. Roberts, M. M. Flanders, 2005, Clinical chemistry.

Acquired heparinlike anticoagulant in a patient with metastatic breast carcinoma.

G. Rodgers, L. Corash, 1985, The Western journal of medicine.

Inherited coagulation disorders

G. Rodgers, J. Powell, 2013 .

High prevalence of overweight/obesity in adult persons with hemophilia in Utah and a review of the literature

A. Presson, P. Bray, G. Rodgers, 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

The PT and the pendulum.

S. Florell, G. Rodgers, 1996, American journal of clinical pathology.

Lupus anticoagulant in the acquired immunodeficiency syndrome.

G. Rodgers, D. Abrams, E. Bloom, 1986, JAMA.

Real-World Data on the Effectiveness and Safety of wilate for the Treatment of von Willebrand Disease

K. Khair, G. Rodgers, D. Matino, 2021, TH Open.

Superwarfarin poisoning: A report of two cases and review of the literature

G. Rodgers, Joseph E. Spahr, J. Maul, 2007, American journal of hematology.

Alterations in sensitivity to calcium and enzymatic hydrolysis of membranes from sickle cell disease and trait erythrocytes

G. Rodgers, Kathrine Christensen, Julie Dee Bell, 2003, American journal of hematology.

Disseminated intravascular coagulation: Clinical and laboratory aspects

G. Rodgers, Michael J. Carey, 1998, American journal of hematology.

The role of renal adenosine 3',5'-monophosphate in the control of erythropoietin production.

G. Rodgers, J. Fisher, W. George, 1975, The American journal of medicine.

Acquired amegakaryocytic thrombocytopenic purpura

G. Rodgers, T. Werner, N. Agarwal, 2006, American journal of hematology.

Elevated cyclic GMP concentrations in rabbit bone marrow culture and mouse spleen following erythropoietic stimulation.

G. Rodgers, J. Fisher, W. George, 1976, Biochemical and biophysical research communications.

siRNA-knockdown of ADAMTS-13 modulates endothelial cell angiogenesis.

Eun Ho Kim, Manfai Lee, G. Rodgers, 2017, Microvascular research.

Overview of platelet physiology and laboratory evaluation of platelet function.

G. Rodgers, 1999, Clinical obstetrics and gynecology.

Cancer- and chemotherapy-induced anemia.

M. Millenson, C. Cleeland, D. Cella, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

M. Mitchell, G. Rodgers, D. Branch, 1996, Prostaglandins.

Evidence of increased angiogenesis in patients with acute myeloid leukemia.

G. Rodgers, P. Shami, J. Hussong, 2000, Blood.

Lactate stimulation of renal cortical adenylate cyclase: a mechanism for erythropoietin production following cobalt treatment or hypoxia.

G. Rodgers, J. Fisher, W. George, 1974, The Journal of pharmacology and experimental therapeutics.

Severe Postoperative Immune‐Mediated Coagulopathy Associated with Bovine Thrombin Exposure

L. Kraiss, G. Rodgers, 2010 .

Immune-mediated Coagulopathy Associated With Topical Bovine Thrombin: Review of the Pediatric Literature

G. Rodgers, 2011, Journal of pediatric hematology/oncology.

Patient Safety in Surgery Building an Immune-mediated Coagulopathy Consensus: Early Recognition and Evaluation to Enhance Post-surgical Patient Safety Evaluation and Treatment of Acquired Coagulopathy Consensus (retacc) Panel Bleeding Cases Non-bleeding Cases Total † Evaluation and Diagnosis

G. Rodgers, Stacy A. Voils, M. Creer, 2022 .

Anaphylactoid reactions to vascular graft material presenting with vasodilation and subsequent disseminated intravascular coagulation.

J. Weiler, M. Roizen, M. Shuman, 1989, Anesthesiology.

Testing for hereditary thrombophilia: a retrospective analysis of testing referred to a national laboratory

A. Phansalkar, G. Rodgers, B. Jackson, 2008, BMC clinical pathology.

Detection of occult cobalamin deficiency by magnetic resonance imaging

G. Rodgers, Margaret K Yu, 2000, American journal of hematology.

Prolonged hypofibrinogenemia and protein C activation after envenoming by Echis carinatus sochureki.

G. Rodgers, J. L. Glenn, R. Whatley, 1991, The American journal of tropical medicine and hygiene.

Acquired coagulation disorders

G. Rodgers, 2013 .

Update on selected inherited venous thrombotic disorders

G. Rodgers, R. Robetorye, 2001, American journal of hematology.

Sensitivity of the activated partial thromboplastin time, the dilute Russell's viper venom time, and the kaolin clotting time for the detection of the lupus anticoagulant: a direct comparison using plasma dilutions

G. Rodgers, D. Branch, B. Martin, 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Book Review:Wintrobe’s Clinical Hematology, 10th Edition

G. Rodgers, J. Lukens, G. R. Lee, 1999 .

How I treat cancer-associated anemia

G. Rodgers, J. Gilreath, 2020 .

Are eltrombopag plasma and skin hyperpigmentation related? The eyes have it

G. Rodgers, J. Gilreath, Amanda L Kurtti, 2018, American journal of hematology.

Thrombocytopenia: Pathophysiology and classification

G. Rodgers, 2013 .

Continuous infusion of human plasma‐derived von Willebrand factor concentrate as an effective therapy in a patient with acquired von Willebrand disease

G. Rodgers, S. Patel, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Evaluation of Rhesus Rotavirus Monovalent and Tetravalent Reassortant Vaccines in US Children

R. Glass, M. Pichichero, M. Rennels, 1995 .

Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.

R. Glass, D. Bernstein, D. Sack, 1995, JAMA.

Current quandaries in cancer-associated anemia.

G. Rodgers, J. Gilreath, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Biochemical characterization of procoagulant albumin.

G. Rodgers, C. Parker, C. Dameron, 1997, Thrombosis research.

Procoagulant Albumin Increases Vascular Endothelial Cell Prostacyclin Secretion

G. Rodgers, Lihua Liu, C. Parker, 1995, Thrombosis and Haemostasis.

Bioassay of procoagulant albumin in human plasma.

G. Rodgers, C. Parker, A. Grosset, 1994, Thrombosis research.

Regulation of endothelial cell protein C activation and fibrinolysis by procoagulant albumin.

G. Rodgers, C. Parker, B. Wilson, 1993, Thrombosis research.

Prothrombin is activated on vascular endothelial cells by factor Xa and calcium.

M. Shuman, G. Rodgers, Marc A. Shuman, 1983, Proceedings of the National Academy of Sciences of the United States of America.

The number of receptors for factor VII correlates with the ability of cultured cells to initiate coagulation.

M. Shuman, G. Rodgers, G. Broze, 1984, Blood.

Identity of the tissue factor‐inducing activity in human plasma

G. Rodgers, 2001 .

Identity of the tissue factor-inducing activity in human plasma.

G. Rodgers, 2001, British journal of haematology.

Regulation of Endothelial Cell Protein C Activation by Native and Oxidized Low Density Lipoprotein

R. E. Pitas, G. Rodgers, B. Wilson, 1992, Seminars in thrombosis and hemostasis.

How I treat Cancer Anemia.

G. Rodgers, J. Gilreath, 2020, Blood.

Hypoprothrombinemia associated with interleukin-2 therapy: correction with vitamin K.

W. Samlowski, G. Rodgers, J. Ward, 1992, Journal of immunotherapy : official journal of the Society for Biological Therapy.

NCCN Guidelines Version 3.2014 Panel Members Cancer- and Chemotherapy-Induced Anemia

M. Millenson, D. Cella, B. Djulbegovic, 2014 .

The accuracy of activated partial thromboplastin times when drawn through a peripherally inserted central catheter

G. Rodgers, B. Markewitz, M. Rondina, 2006, American journal of hematology.

Established venous thromboembolism therapies: heparin, low molecular weight heparins, and vitamin K antagonists, with a discussion of heparin-induced thrombocytopenia.

R. Pendleton, G. Rodgers, R. Hull, 2010, Clinics in chest medicine.

Perioperative management of antithrombotic therapy in cardiovascular patients.

M. Nuttall, G. Rodgers, 2011, Methodist DeBakey cardiovascular journal.

Venous thromboembolism prevention in the acutely ill medical patient: A review of the literature and focus on special patient populations

R. Pendleton, G. Rodgers, Michelle Wheeler, 2005, American journal of hematology.

Upshaw-Schulman syndrome and pregnancy: successful management with plasma infusions

G. Rodgers, R. Gangaraju, 2016, Annals of Hematology.

Performance of a clinical prediction score for thrombotic thrombocytopenic purpura in an independent cohort

G. Rodgers, Andrew M Wilson, M. J. Bentley, 2013, Vox sanguinis.

The utility of patient characteristics in predicting severe ADAMTS13 deficiency and response to plasma exchange

G. Rodgers, R. Blaylock, Melissa J. Bentley, 2010, Transfusion.

Improving the laboratory diagnosis of heparin-induced thrombocytopenia.

G. Rodgers, 2003, The American journal of medicine.

Vascular smooth muscle cells synthesize, secrete and express coagulation factor V.

G. Rodgers, 1988, Biochimica et biophysica acta.

Utilization and outcomes of enoxaparin treatment for deep‐vein thrombosis in a tertiary‐care hospital

G. Rodgers, Kristine B. Gilbert, 2000, American journal of hematology.

The preparation of a sensitive partial thromboplastin reagent from bovine brain

G. Rodgers, D. Branch, B. Martin, 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Blastic transformation of a well-differentiated monocytic leukemia: changes in cytochemical and cell surface markers.

G. Rodgers, C. Ries, D. Bainton, 1982, Leukemia research.

Miscellaneous causes of thrombocytopenia

G. Rodgers, A. Agarwal, 2013 .

Parenteral iron therapy: a single institution's experience over a 5-year period.

G. Rodgers, S. B. Silverstein, Christopher A Laman, 2005, Journal of the National Comprehensive Cancer Network : JNCCN.

Comparative evaluation of the safety and effectiveness of rivaroxaban (riva) and enoxaparin (enox) for treatment of venous thromboembolism (VTE) in cancer patients.

G. Rodgers, D. Stenehjem, J. Gilreath, 2017 .

To IRB or not to IRB? That is no longer the question.

G. Rodgers, C. M. Lehman, 2001, American journal of clinical pathology.

Treatment strategies for myeloid growth factors and intravenous iron: when, what, and how?

J. Crawford, G. Rodgers, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Acquired von Willebrand syndrome in monoclonal gammopathy – A scoping review on hemostatic management

P. Bray, G. Rodgers, Mouhamed Yazan Abou-Ismail, 2021, Research and practice in thrombosis and haemostasis.

ADAMTS13 and its variants promote angiogenesis via upregulation of VEGF and VEGFR2

Manfai Lee, G. Rodgers, Juan Xiao, 2014, Cellular and Molecular Life Sciences.

A perspective on the evolution of management of cancer- and chemotherapy-induced anemia.

G. Rodgers, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Elevation of renal cyclic GMP concentrations and plasma lysosomal enzyme activity following cobalt treatment in rats.

G. Rodgers, J. Fisher, W. George, 1974, Biochemical and biophysical research communications.

Renal cyclic GMP and cholinergic mechanisms in erythropoietin production.

G. Rodgers, J. Fisher, W. George, 1975, Life sciences.

ADAMTS13 and Angiogenesis

Manfai Lee, G. Rodgers, 2015 .

Endothelium: Angiogenesis and the regulation of hemostasis

G. Rodgers, P. Shami, 2013 .

Thrombocytosis and essential thrombocythemia

G. Rodgers, R. Means, 2013 .

Prevalence of heparin in samples submitted for lupus anticoagulant testing.

G. Rodgers, K. Smock, N. Sangle, 2011, Laboratory hematology : official publication of the International Society for Laboratory Hematology.

A second case of prothrombin puerto rico I in the united states

G. Rodgers, S. Kling, Kimberly A. Jones, 2007, American journal of hematology.

Response to Girolami et al.

G. Rodgers, S. Kling, 2008 .

Developmental hemostasis: age‐specific differences in the levels of hemostatic proteins: a rebuttal

G. Rodgers, 2014, Journal of thrombosis and haemostasis : JTH.

Plasma glycocalicin.

G. Rodgers, T. Hamill, 1988, New England Journal of Medicine.

Wintrobe's clinical hematology: Fourteenth edition

F. Appelbaum, D. Arber, A. Dispenzieri, 2018 .

Guidelines for the use of erythropoietic growth factors in patients with chemotherapy-induced anemia.

G. Rodgers, 2006, Oncology.

Whole Exome Sequencing (WES) indentifies a mutation in ALPK1 responsible for a novel, autosomal dominant disorder of vision loss, splenomegaly, and pancytopenia

Krista I Kinard, C. Huff, K. Digre, 2013 .

High-molecular weight iron dextran: a wolf in sheep's clothing?

D. Cella, G. Chertow, G. Rodgers, 2008, Journal of the American Society of Nephrology : JASN.

A concept for the control of kidney production of erythropoietin involving prostaglandins and cyclic nucleotides.

W. Jubiz, G. Rodgers, J. Fisher, 1978, Contributions to nephrology.

Testing for Inherited Bleeding Disorders

G. Rodgers, 2015 .

Dynamic dosing of romiplostim in patients with immune thrombocytopenia purpura: Two case reports

G. Rodgers, D. Stenehjem, C. Parker, 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients.

R. Pendleton, G. Rodgers, M. Rondina, 2010, Thrombosis Research.

Testing for Inherited and Acquired Thrombotic Disorders

G. Rodgers, 2015 .

An inherited disorder with splenomegaly, cytopenias, and vision loss

F. Clayton, K. Digre, D. Creel, 2012, American journal of medical genetics. Part A.

Activation of coagulation factor V by calcium-dependent proteinase.

G. Rodgers, W. Kane, D. E. Goll, 1987, Biochimica et biophysica acta.

Testing for hereditary thrombophilia: a retrospective analysis of testing referred to a national laboratory

A. Phansalkar, G. Rodgers, B. Jackson, 2008, BMC clinical pathology.

Switching haemophilia products and inhibitor risk: a United States' perspective

G. Rodgers, D. Nance, 2015, European journal of haematology.